Literature DB >> 23553438

Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service.

Tze Kin Lau1, Fu Man Jiang, Robert J Stevenson, Tsz Kin Lo, Lin Wai Chan, Mei Ki Chan, Pui Shan Salome Lo, Wei Wang, Hong-Yun Zhang, Fang Chen, Kwong Wai Choy.   

Abstract

OBJECTIVE: To report secondary or additional findings arising from introduction of non-invasive prenatal testing (NIPT) for aneuploidy by whole genome sequencing as a clinical service.
METHODS: Five cases with secondary findings were reviewed.
RESULTS: In Case 1, NIPT revealed a large duplication in chromosome 18p, which was supported by arrayCGH of amniocyte DNA, with final karyotype showing mosaic tetrasomy 18p. In Case 2, a deletion in the proximal long arm of chromosome 18 of maternal origin was suspected and confirmed by arrayCGH of maternal white cell DNA. In Case 3, NIPT was negative for trisomies 21 and 18. In-depth analysis for deletions/duplications was requested when fetal structural anomalies were detected at routine scan. A deletion in the proximal long arm of chromosome 3 was found and confirmed by karyotyping. In Case 4, NIPT correctly predicted confined placental mosaicism with triple trisomy involving chromosomes X, 7 and 21. In Case 5, NIPT correctly detected a previously unknown maternal mosaicism for 45X.
CONCLUSION: Non-invasive prenatal testing is able to detect a wide range of fetal, placental and maternal chromosomal abnormalities. This has important implications on patient counseling when an abnormality is detected by NIPT.
© 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23553438     DOI: 10.1002/pd.4076

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  29 in total

1.  Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management.

Authors:  Baran Bayindir; Luc Dehaspe; Nathalie Brison; Paul Brady; Simon Ardui; Molka Kammoun; Lars Van der Veken; Klaske Lichtenbelt; Kris Van den Bogaert; Jeroen Van Houdt; Hilde Peeters; Hilde Van Esch; Thomy de Ravel; Eric Legius; Koen Devriendt; Joris R Vermeesch
Journal:  Eur J Hum Genet       Date:  2015-01-14       Impact factor: 4.246

2.  Will the introduction of non-invasive prenatal testing for Down's syndrome undermine informed choice?

Authors:  Caroline Silcock; Lih-Mei Liao; Melissa Hill; Lyn S Chitty
Journal:  Health Expect       Date:  2014-02-20       Impact factor: 3.377

3.  Placental mosaicism for Trisomy 13: a challenge in providing the cell-free fetal DNA testing.

Authors:  Xiang-Yin Liu; Hong-Guo Zhang; Rui-Xue Wang; Shuang Chen; Xiao-Wei Yu; Rui-Zhi Liu
Journal:  J Assist Reprod Genet       Date:  2014-02-05       Impact factor: 3.412

Review 4.  Prenatal and pre-implantation genetic diagnosis.

Authors:  Joris Robert Vermeesch; Thierry Voet; Koenraad Devriendt
Journal:  Nat Rev Genet       Date:  2016-09-15       Impact factor: 53.242

5.  Maternal iAMP21 acute lymphoblastic leukemia detected on prenatal cell-free DNA genetic screening.

Authors:  Marlise R Luskin; Marie N Discenza; Sarah Rae Easter; Paola Dal Cin; Renius Owen; Bernard Ilagan; Meredith Masiello; Andrew A Lane
Journal:  Blood Adv       Date:  2017-08-15

Review 6.  Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease.

Authors:  E S Taglauer; L Wilkins-Haug; D W Bianchi
Journal:  Placenta       Date:  2013-12-01       Impact factor: 3.481

Review 7.  Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road?

Authors:  Diana W Bianchi; Louise Wilkins-Haug
Journal:  Clin Chem       Date:  2013-11-19       Impact factor: 8.327

Review 8.  Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.

Authors:  Kathryn J Gray; Louise E Wilkins-Haug
Journal:  Pediatr Radiol       Date:  2018-03-17

Review 9.  Genome-Wide Sequencing for Prenatal Detection of Fetal Single-Gene Disorders.

Authors:  Ignatia B van den Veyver; Christine M Eng
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-07       Impact factor: 6.915

10.  Biological explanations for discordant noninvasive prenatal test results: Preliminary data and lessons learned.

Authors:  Louise Wilkins-Haug; Chengsheng Zhang; Eliza Cerveira; Mallory Ryan; Adam Mil-Homens; Qihui Zhu; Honey Reddi; Charles Lee; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2018-05       Impact factor: 3.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.